Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00419822 · ClinicalTrials.gov registry record · NA

Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients

A NA study of Breast Cancer, sponsored by Legacy Health System.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00419822 is a NA study of Breast Cancer that has completed, run by Legacy Health System. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00419822, a NA study of Breast Cancer, has completed, sponsored by Legacy Health System.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study is for the woman who will have axillary (armpit) surgery as part of their breast cancer treatment. The purpose of this project is to evaluate if acupuncture is helpful to control pain and improve range of motion (arm movement). Another goal is to find out if women have an improvement in their quality of life. This study is being done in collaboration with the Oregon College of Oriental Medicine (OCOM).

Conditions Studied

Interventions

  • PROCEDURE Acupuncture
  • PROCEDURE Sham Acupuncture
  • OTHER Patient to receive standard care without Acupuncture or Sham Acupuncture.

Study Locations (1)

Oregon

  • Legacy Good Samaritan Hospital and Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-09
Phase NA

Sponsor

Legacy Health System

21 total trials

What the Registry Record Tells You About NCT00419822

The ClinicalTrials.gov registry entry for NCT00419822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.

NCT00419822 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT00419822 about?

NCT00419822 is a clinical study titled "Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients". This study is for the woman who will have axillary (armpit) surgery as part of their breast cancer treatment. The purpose of this project is to evaluate if acupuncture is helpful to control pain and improve range of motion (arm movement). Another goal is to find out if women have an improvement in t...

What is the current status of trial NCT00419822?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-09.

What conditions does trial NCT00419822 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00419822?

The interventions under investigation include: Acupuncture (PROCEDURE), Sham Acupuncture (PROCEDURE), Patient to receive standard care without Acupuncture or Sham Acupuncture. (OTHER).

Who is sponsoring clinical trial NCT00419822?

This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00419822 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.